Anti-ELOVL7 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution

Not available outside of the UK & Ireland.

Biochem/physiol Actions

ELOVL7 catalyses the elongation of long chain fatty acids, preferably saturated long chain fatty acids. Elovl7 exhibited activity towards C16-C20 acyl coenzyme A with maximum affinity towards carbon length of C18. Elovl7 expression is regulated by sterol regulatory element-binding protein 1 (SREBP1) and also by other lipogenic enzymes. The expression levels of Elovl7 is higher in prostate cancer leading to its progression.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Features and Benefits

Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more.

General description

ELOVL (Elongation of very long chain fatty acids) fatty acid elongase 7 is expressed in most tissues except heart and skeletal muscles. In human chromosome, the gene ELOVL7 is localised on 5q12.1.

Immunogen

ELOVL7 antibody was raised against a 15 amino acid peptide near the amino terminus of human ELOVL7.

Linkage

The action of this antibody can be blocked using blocking peptide SBP3500390.

Physical form

Supplied in PBS with 0.02% sodium azide.